Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$209.11
+3.66%
Mkt Cap $29.99B
Analyst Ratings
Buy
26
Hold
20
Sell
0
Price Target (129 analysts)
$218.32
Range $185.00 – $260.00
Implied Upside
+4.4%
Consensus $218.32 vs current $209.11